Insulin treatment for type 2 diabetes: When to start, which to use

被引：33

作者：

Hamaty, Marwan ^{[1
]}

机构：

[1] Cleveland Clin, Endocrine & Metab Inst, Ctr Diabet, Dept Endocrinol Diabet & Metab, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2011年 / 78卷 / 05期

关键词：

TO-TARGET TRIAL; BASAL-BOLUS REGIMEN; GLYCEMIC CONTROL; NPH INSULIN; PARALLEL-GROUP; OPEN-LABEL; SEVERE HYPOGLYCEMIA; PLUS METFORMIN; BLOOD-GLUCOSE; DOUBLE-BLIND;

D O I：

10.3949/ccjm.78a.10051

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In type 2 diabetes mellitus, oral hypoglycemic agents and analogues of glucagon-like peptide-1 provide adequate glycemic control early in the disease. Insulin therapy becomes necessary for those with advanced disease. Further, some experts recommend electively starting insulin therapy in early diabetes. This review addresses practical approaches to insulin therapy, particularly when it is indicated and which regimen to use.

引用

页码：332 / 342

页数：11

共 43 条

[1] Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey [J].

Akram, Kamran ;

Pedersen-Bjergaard, Ulnik ;

Borch-Johnsen, Knut ;

Thorsteinsson, Birger .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (06) :402-408

[2]

Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]

[3]

[Anonymous], 1995, Diabetes, V44, P1249

[4] Adjust to target in type 2 diabetes - Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine [J].